• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

J Diabetes Metab Disord . Risk indicators associated with in-hospital mortality and severity in patients with diabetes mellitus and confirmed or cli

tetano

Editor, Senior Moderator
J Diabetes Metab Disord


. 2021 Jan 7;1-11.
doi: 10.1007/s40200-020-00701-2. Online ahead of print.
Risk indicators associated with in-hospital mortality and severity in patients with diabetes mellitus and confirmed or clinically suspected COVID-19


Marzieh Pazoki[SUP] 1 [/SUP], Mohammad Keykhaei[SUP] 2 [/SUP], Samira Kafan[SUP] 1 [/SUP], Mahnaz Montazeri[SUP] 3 [/SUP], Mojgan Mirabdolhagh Hazaveh[SUP] 4 [/SUP], Mehran Sotoodehnia[SUP] 5 [/SUP], Sina Kazemian[SUP] 2 [/SUP], Mohammad Talebpour[SUP] 6 [/SUP], Haleh Ashraf[SUP] 7 8 [/SUP], Reza Shariat Moharari[SUP] 9 [/SUP], Fazeleh Majidi[SUP] 8 [/SUP], Nazanin Hedayati Amlashi[SUP] 8 [/SUP], Sara Zare[SUP] 8 [/SUP], Maryam Fathi[SUP] 8 [/SUP], Zohre Azimbeik[SUP] 8 [/SUP], Mehdi Ebrahimi[SUP] 4 [/SUP]



Affiliations

Abstract

Purpose: This study aims to investigate risk indicators of in-hospital mortality and severity of coronavirus disease-2019 (COVID-19) in patients with diabetes mellitus (DM).
Methods: In this retrospective study, we studied patients with COVID-19 referred to Sina Hospital, Tehran, Iran, from February 20 to May 14, 2020. Patients with either a positive real-time reverse-transcriptase polymerase-chain-reaction test of swab specimens or high clinical suspicion according to the World Health Organization interim guidance were included. We accurately divided all patients into two groups based on diabetes affection and followed-up patients with DM based on incurring death, severe COVID-19, and in-hospital complications.
Results: We enrolled 574 patients with COVID-19 in the final analysis, of whom 176 (30.7%) patients had DM. In this study, 104 (18.1%) patients deceased, and 380 (66.2%) patients incurred severe COVID-19. We found that COVID-19 patients with DM had a significantly higher mortality rate (P value<0.001), severe disease (P value<0.001), and in-hospital complications (all P values<0.05). Besides that, in patients with DM, admission temperature (odds ratio (OR): 1.69, P value: 0.024), oxygen saturation (OR: 0.92, P value: 0.004), and urea (OR: 1.01, P value: 0.048) were independent risk indicators of in-hospital mortality. In addition, subgroup analysis of diabetic patients based on admission glucose level showed significant differences between these groups regarding acute cardiac injury (P value: 0.044) and acute liver injury (P value: 0.002).
Conclusions: Patients with DM admitted with lower oxygen saturation, elevated temperature, and higher urea are more susceptible to progress to more severe COVID-19 and poor prognosis. This indicates a necessity for more precise care during hospitalization for these patients.
Supplementary information: The online version contains supplementary material available at 10.1007/s40200-020-00701-2.

Keywords: COVID-19; Diabetes mellitus; Hyperglycemia; Mortality; Severity.
 
Back
Top Bottom